Should we stay or should we go: assessment of the need for the implantation of a definite pacemaker in a population of acute coronary syndrome that evolved in advanced atrioventricular block
Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome